Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 185891, 6 pages
http://dx.doi.org/10.1155/2015/185891
Research Article

Intellectual Impairment in Patients with Newly Diagnosed HIV Infection in Southwestern Nigeria

1Neurology Unit, Department of Medicine, Federal Medical Center, Owo 341, Ondo State, Nigeria
2Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University, 5026 Salzburg, Austria
3Department of Neurology, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany
4Neurology Unit, Department Medicine, University of Benin Teaching Hospital, Benin 300, Nigeria
5Department of Community Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife 220, Osun State, Nigeria
6Department of Community Health, Obafemi Awolowo University, Ile-Ife 220, Osun State, Nigeria
7Department of Community Health, Federal Medical Centre, Owo 341, Ondo State, Nigeria
8Department of Dermatology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife 220, Osun State, Nigeria
9Clinical Psychology Unit, Department of Mental Health, Obafemi Awolowo University, Ile-Ife 220, Osun State, Nigeria

Received 5 December 2014; Accepted 17 January 2015

Academic Editor: András Palotás

Copyright © 2015 Taofiki A. Sunmonu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Brun-Vézinet and C. Charpentier, “Update on the human immunodeficiency virus,” Médecine et Maladies Infectieuses, vol. 43, no. 5, pp. 177–184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. H. Alkali, S. A. Bwala, Y. W. Nyandaiti, and M. A. Danesi, “NeuroAIDS in sub-Saharan Africa: a clinical review,” Annals of African Medicine, vol. 12, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Zwahlem, R. Harris, M. May et al., “Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries,” International Journal of Epidemiology, vol. 38, no. 6, pp. 1624–1633, 2009. View at Publisher · View at Google Scholar
  4. D. B. Clifford and B. M. Ances, “HIV-associated neurocognitive disorder,” The Lancet Infectious Diseases, vol. 13, no. 11, pp. 976–986, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Cattie, K. Doyle, E. Weber, I. Grant, and S. P. Woods, “Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning,” Journal of Clinical and Experimental Neuropsychology, vol. 34, no. 9, pp. 906–918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. Sevigny, S. M. Albert, M. P. McDermott et al., “An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection,” Archives of Neurology, vol. 64, no. 1, pp. 97–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. P. Woods, M. S. Dawson, E. Weber et al., “Timing is everything: antiretroviral non-adherence is associated with impairment in time-based prospective memory,” Journal of the International Neuropsychological Society, vol. 15, no. 1, pp. 42–52, 2009. View at Publisher · View at Google Scholar
  8. C. H. Hinkin, D. J. Hardy, K. I. Mason et al., “Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse,” AIDS, vol. 18, no. supplement 1, pp. S19–S25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. H. Hinkin, S. A. Castellon, R. S. Durvasula et al., “Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity,” Neurology, vol. 59, no. 12, pp. 1944–1950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Royal III, M. Cherner, J. Carr et al., “Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria,” Journal of NeuroVirology, vol. 18, no. 3, pp. 191–199, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. L. D'Elia, P. Satz, and D. Schretlen, “Wechsler Memory Scale: a critical appraisal of the normative studies,” The Journal of Clinical and Experimental Neuropsychology, vol. 11, no. 4, pp. 551–568, 1989. View at Publisher · View at Google Scholar · View at Scopus
  12. T. A. Sunmonu, M. A. Komolafe, A. O. Ogunrin, B. Y. Oladimeji, and A. Ogunniyi, “Intellectual impairment in patients with epilepsy in Ile-Ife, Nigeria,” Acta Neurologica Scandinavica, vol. 118, no. 6, pp. 395–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. McCarthy, “Wechsler Adult intelligence scale: a pilot study in a Nigerian Technical College,” West African Journal of Education, vol. 17, pp. 221–228, 1973. View at Google Scholar
  14. K. Robertson, J. Liner, J. Hakim et al., “NeuroAIDS in Africa,” Journal of NeuroVirology, vol. 16, no. 3, pp. 189–202, 2010. View at Publisher · View at Google Scholar
  15. K. Blackstone, D. J. Moore, D. R. Franklin et al., “Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings,” The Clinical Neuropsychologist, vol. 26, no. 6, pp. 894–908, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Hasbun, J. Eraso, S. Ramireddy et al., “Screening for neurocognitive impairment in HIV individuals: the utility of the montreal cognitive assessment test,” Journal of AIDS and Clinical Research, vol. 3, no. 10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. G. Habib, A. M. Yakasai, L. F. Owolabi et al., “Neurocognitive impairment in HIV-1-infected adults in sub-Saharan Africa: a systematic review and meta-analysis,” International Journal of Infectious Diseases, vol. 17, no. 10, pp. e820–e831, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. O. O. Oshinaike, A. A. Akinbami, O. O. Ojo, I. F. Ojini, U. N. Okubadejo, and A. M. Danesi, “Comparison of the minimental state examination scale and the international HIV dementia scale in assessing cognitive function in nigerian HIV patients on antiretroviral therapy,” AIDS Research and Treatment, vol. 2012, Article ID 581531, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. L. G. Chan, N. Kandiah, and A. Chua, “HIV-associated neurocognitive disorders (HAND) in a South Asian population—contextual application of the 2007 criteria,” BMJ Open, vol. 2, no. 1, Article ID 000662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. R. Robertson, N. Nakasujja, M. Wong et al., “Pattern of neuropsychological performance among HIV positive patients in Uganda,” BMC Neurology, vol. 7, article 8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Moore, M. J. P. Roediger, L. E. Eberly et al., “Identification of an abbreviated test battery for detection of HIV- associated neurocognitive impairment in early-managed HIV-infected cohort,” PLoS ONE, vol. 7, no. 11, Article ID e47310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. Heaton, D. B. Clifford, D. R. Franklin et al., “HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: charter study,” Neurology, vol. 75, no. 23, pp. 2087–2096, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Fischer-Smith, S. Croul, A. E. Sverstiuk et al., “CNS invasion by Cd14+/Cd16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection,” Journal of NeuroVirology, vol. 7, no. 6, pp. 528–541, 2001. View at Publisher · View at Google Scholar
  24. L. Zhou, R. Rua, T. Ng et al., “Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia,” BMC Infectious Diseases, vol. 9, article 192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. D. Kanmogne, C. T. Kuate, L. A. Cysique et al., “HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon,” BMC Neurology, vol. 10, article 60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Foley, M. L. Ettenhofer, M. S. Kim, N. Behdin, S. A. Castellon, and C. H. Hinkin, “Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline,” Applied Neuropsychology: Adult, vol. 19, no. 1, pp. 16–25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Nichols, J. Bethel, P. A. Garvie et al., “Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus,” Journal of Adolescent Health, vol. 53, no. 6, pp. 763–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C. H. Hong, C. Falvey, T. B. Harris et al., “Anemia and risk of dementia in older adults: findings from the Health Abc study,” Neurology, vol. 81, no. 6, pp. 528–533, 2013. View at Publisher · View at Google Scholar
  29. S. Dolan, A. Montagno, S. Wilkie et al., “Neurocognitive function in HIV-infected patients with low weight and weight loss,” Journal of Acquired Immune Deficiency Syndromes, vol. 34, no. 2, pp. 155–164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Wang, Y. So, E. Vittinghoff et al., “Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis,” Journal of Acquired Immune Deficiency Syndromes, vol. 8, no. 1, pp. 75–82, 1995. View at Google Scholar · View at Scopus